Fundraising FoxInaedis
Princeton, US · 2 known investors
Find your way into Inaedis
Sign up to see every warm intro you have to Inaedis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inaedis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.
Founders & leadership
Investors · 2
How we know: New Jersey Economic Development Authority's portfolio page · Not right? Tell us
.jpeg){kind=logo}
How we know: Roadrunner Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Inaedis do?
- Inaedis develops RTAD (Room Temperature Ambient Drying), a biopharmaceutical formulation platform that enables alternative drug delivery routes for monoclonal antibodies and biologics, including subcutaneous, inhaled, and intranasal administration. The platform reduces manufacturing risk and cost for pharmaceutical companies while improving patient access through room-temperature stability and simplified administration.
- Who founded Inaedis?
- Inaedis was founded by Maksim Mezhericher, Howard A. Stone.
- Who are Inaedis's investors?
- Inaedis's investors include New Jersey Economic Development Authority, Roadrunner Ventures.
- Where is Inaedis headquartered?
- Inaedis is headquartered in Princeton, US.